Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment

January 2024 in “ Skin Appendage Disorders ”

Anabella Watts‐Santos, David Ancona‐Lezama, Jose A Figueroa-Sanchez, Daniela Mares-Custodio, Verónica Garza-Rodríguez

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pmc.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Eyebrow and Eyelash Alopecia: A Clinical Review

6 citations , October 2022 in “American journal of clinical dermatology”

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

research Pathogenesis and Treatment Options for Chemotherapy-Induced Alopecia: A Systematic Review

34 citations , January 2018 in “International Journal of Dermatology”

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

research Madarosis: A Qualitative Study to Assess Perceptions and Experience of Australian Patients with Early Breast Cancer Treated with Taxane-Based Chemotherapy

11 citations , August 2017 in “Supportive care in cancer”

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

research Pathobiology of Chemotherapy-Induced Hair Loss

218 citations , January 2013 in “The Lancet Oncology”

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.